Risks of Cardiac Valve Regurgitation and Heart Failure Associated with Ergot- and Non-Ergot-Derived Dopamine Agonist Use in Patients with Parkinson’s Disease: A Systematic Review of Observational Studies

Pergolide Associated Cardiac Valvulopathy Based on Ontario Administrative Data

(2014) Cindy Zadikoff et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients

(2014) Santiago Perez-Lloret et al.   Expert Opinion On Drug Safety

Risk of Heart Failure Associated with Dopamine Agonists: A Nested Case–Control Study

(2013) P. H. Hsieh et al.   DRUGS & AGING

Multiple valvular regurgitation associated with bromocriptine therapy

(2012) Thomas Cautres et al.   Archives of Cardiovascular Diseases

Risk of Cardiac Valve Regurgitation with Dopamine Agonist use in Parkinsonʼs Disease and Hyperprolactinaemia

(2011) Gianluca Trifirò et al.   DRUG SAFETY

The risk of valvular regurgitation in patients with Parkinson's disease treated with dopamine receptor agonists

(2011) Vibeke Guldbrand Rasmussen et al.   MOVEMENT DISORDERS

Dopamine agonist use and the risk of heart failure

(2011) Christel Renoux et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease

(2011) M. Mostafa Mokhles et al.   PHARMACOLOGICAL RESEARCH

Regression of Cardiac Valvulopathy Related to Ergot-Derived Dopamine Agonists

(2010) Renzo Zanettini et al.   Cardiovascular Therapeutics

Dopamine Receptor Agonists for the Treatment of Early or Advanced Parkinsonʼs Disease

(2010) Santiago Perez-Lloret et al.   CNS DRUGS

Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson’s disease: a systematic review

(2009) Malcolm Steiger et al.   JOURNAL OF NEURAL TRANSMISSION

B-type natriuretic peptide and cardiovalvulopathy in Parkinson disease with dopamine agonist

(2009) H. Watanabe et al.   NEUROLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

The frequency of cardiac valvular regurgitation in Parkinson's disease

(2008) Kazuo Yamashiro et al.   MOVEMENT DISORDERS

Bromocriptine use and the risk of valvular heart disease

(2008) Louis C.S. Tan et al.   MOVEMENT DISORDERS